Si-Bone SIBN
NASDAQ SIBN
$19.96 +0.48 (+2.46%)
At close: Aug 21, 2026 · 4:00 PM EDT

Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018)

Si-Bone (SIBN) posted quarterly Preferred Stock Liabilities of $118.5 million for Q3 2018, up 27991.94% quarter-over-quarter from $422000.0 in Q4 2017.

Si-Bone (SIBN) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends

Si-Bone's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $118.5 million for Q3 2018.

  • In Q3 2018, Preferred Stock Liabilities changed N/A year-over-year to $118.5 million; the TTM figure through Sep 2018 stood at $118.5 million (changed N/A YoY), while the FY2017 annual figure was $422000.0, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q3 2018 stood at $118.5 million, up from $422000.0 in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $118.5 million in Q3 2018, with the low at $422000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Si-Bone 887.32 Mn 741.38 Mn 44.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2018 118.55 Mn
Dec 31, 2017 422,000.00